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Introduction
Focal cortical dysplasia (FCD), as recognized by Taylor, Bruton, Falconer and Corsellis is a unique type of lesion in epilepsy pathology (Taylor 1971 , Kasper 2010 ). Taylor's focal cortical dysplasia, i.e.
FCD II A and B according to current histopathological classifications (Blümcke 2011) , is characterized by pathognomonic tissue features of dysplastic neurons often accompanied by "balloon cells" (Blümcke 2017 , Aronica 2012 , Taylor 1971 . A large body of evidence has shown that FCD II has an intrinsic epileptogenic potential: epileptic discharges do arise from the lesion itself as shown by lesional samplings with subdural, electrocorticographic and intracerebral recordings (Dubeau 1998 , Palmini 1991 , Chassoux 2012 , single cell electrophysiological techniques (Cepeda 2003) , as well as previous data using magnetoencephalography (MEG) (Morioka 1999 , Bast 2004 , Widjaja 2008 , Ishii 2008 , Sueda 2010 , Wilenius 2013 , Wang 2014 . Overlap of irritative zones and seizure onset zones has been reported for FCD in high rates (Bartolomei 2016) . Extratemporal epileptogenic zones prevail in FCD II due to predilection for cortical areas outside the temporal lobes (Blümcke 2017 , Guerrini 2015 , Aronica 2012 , predominating in frontal and pericentral localisations . Accordingly, seizure semiology often appears complex and surface EEG recordings may not show localized epileptic discharges or ictal patterns at all. Epilepsy surgery offers good chances for FCD II patients (Rössler 2017) , but localizing the epileptogenic zone and surgery is a challenge in FCD II (Guerrini 2015 , Fauser 2012 ) since lesions often reside in close relation to eloquent cortex and lesion borders are not exactly defined by MRI (Tassi 2001) . Currently, many FCD II lesions are visualized presurgically by optimized magnetic resonance imaging (MRI) , Wagner 2011 , Martin 2017 ). However, when subtle and small, then often residing within deep parts of cerebral sulci (Besson 2008) , FCD II can escape visual MRI analysis even at experienced referral centers (Bernasconi 2011 , von Oertzen 2002 . FCD II likely represents the most frequent cause of "nonlesional" focal epilepsy (Bernasconi 2011 , Bonini 2017 . Sophisticated MRI postprocessing methods have been developed in order to increase FCD II detection rates after normal MRI readings (Martin 2017 , Bernasconi 2011 , Wagner 2011 , Huppertz 2005 , Antel 2003 , Bernasconi 2001 including the morphometric analysis program (MAP, Huppertz 2005) . Since MRI/MAP results represent pure structural information and may provide false positive findings (Huppertz 2005) , supporting concordant evidence from other data including methods depicting epileptogenicity is needed in order to plan an epilepsy-surgical strategy.
We here will demonstrate high efficacy and accuracy of magnetoencephalography (MEG) in FCD II and argue for surgically targeting the MEG-MRI-lesion, for this seems to facilitate excellent results.
Patients and Methods
Patients were selected from the database of the epilepsy surgery program at Erlangen Epilepsy Center, Friedrich-Alexander University Erlangen-Nuremberg, Germany. All patients had been investigated for pharmacoresistant focal epilepsy from 2006 to 2016 in order to determine eligibility for epilepsy surgery. Patients selected for this study had either a histopathological verified diagnosis of FCD II and/or characteristic MRI signs of FCD II. MRI criteria were: focal cortical thickening, grey-white matter blurring, white matter signal increase and/or transmantle sign (Wagner 2011) . In addition to comprehensive epilepsy workup (Kral 2002) including non-invasive-video-EEG, MRI imaging and neuropsychological testing, all patients had received a MEG using the same whole-head system (see
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Methods). A total of 21 patients were included in the study. Selected patients had invasive recordings in advance to resective surgery (n=14). All surgical patients had a follow up of at least 1 year.
MRI acquisition and morphometric analysis (MAP)
High resolution MRI imaging had been performed using a 3T Magnetom Trio (Siemens Medical Solutions, Erlangen Germany) with a 32 channel head coil. Sequences included the following: 1) FLAIR (3D-FLAIR, 1x1x1cm; TR 4000, TE 388, matrix 258x256), 2) T1 magnetization prepared rapid gradient echo (MPRAGE, 1x1x1cm, TR 2300, TE 2.98, matrix 256x256). 3D MPRAGE sequences were used to perform morphometric analysis using the MAP software (morphometric analysis program) by Huppertz (Huppertz 2005) . The software compares an individual patient's structural MRI to a scanner-specific database of normal controls. Distribution of grey and white matter is analyzed voxel-wise and yields maps of selected feature parameters of cortical thickness and grey-white boundary sharpness highlighting typical signs of FCD (Huppertz 2005) . All feature maps are also combined into a "combined z-score" map. Only these combined-z-score maps were used for statistical evaluation in the presented study. Anatomical lesion localizations were rated visually and categorized according to Wang (Wang 2014) . We depicted the FCD by using MAP at a z-score threshold >3 in order to calculate distances between the MEG source localization (see below) and the FCD.
Identification of the real FCD was validated based on postsurgical diagnosis and the synopsis of all available findings (i.e. video-EEG, semiology, imaging).
MEG acquisition and analysis
MEG was acquired using a whole-head 248 channel magnetometer system for patient investigations after 2010 (Magnes 3600WH, 4D-Neuroimaging, San Diego, CA, USA) and a two sensor gradiometer system with 2x37 channels before (Magnes II, 4D-Neuroimaging). Duration of recordings varied depending on the clinical needs and respective investigation, e.g. for functional mapping and/or epileptic focus localization. Recordings were conducted in supine position. Patients were asked to keep their eyes closed. If they fell asleep, they were not woken up before of the end of the complete recording. With the Magnes 3600WH system, data were acquired using a sample rate of 508Hz and an analogue 0.1Hz high pass filter. Noise reduction was performed offline, taking reference gradiometers and magnetometers into account (manufacturer's software). Recordings with the Magnes II system utilized a sample rate of 520Hz, an analogue 1Hz high pass filter and no offline noise reduction. For analysis, an additional digital 1-70Hz and a 50Hz notch filter were applied.
Epileptic discharges were manually identified and selected by an experience reviewer (SR).
Subsequently, all identified patterns were averaged and submitted to source analysis utilizing single moving dipole localization in spherical volume conductors (Curry 7, Compumedics Neuroscan, Singen, Germany). All patients only presented with a single focal type of spike, i.e. a subclassification of spikes into groups with similar topography and morphology was not necessary. Channels for analysis were restricted to 37 channels centered on the steepest gradient at the spike peak using data from Magnes 3600WH. Dipole localization methodology with both systems was thus comparable. This approach, suggested by the system manufacturer and also used in other studies (Stefan et. al, 2003) removes channels distant from the maximal gradient, which contain mostly unrelated data, thus improving the
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appropriateness of a single dipole model for source analysis. Only resulting dipoles with deviation between measured and modelled field of less than 30% were analysed further. The single best dipole per patient in terms of minimal deviation was superimposed on individual 3D MP-RAGE MRI, and MAP. If two dipoles resulted in equal deviation, the earlier was used. Tables 1 and 2 ).
Analysis
In patients with epilepsy surgery, the relation of MEG localizations, MAP finding and resection cavity was evaluated using postoperative MR images, which were acquired either immediately after the resection using intraoperative 1.5T MRI (Sommer 2013) or 3T MRI at 6 months after surgery. Patient 15 had to be excluded from this analysis, since although undergoing epilepsy surgery, postoperative
MRIs were not available. The degree of resection was evaluated visually: The MEG localization was considered to be resected completely, if it was located within the resection volume. It was classified as partially resected if the localization was located at the border of the resection (within 2cm) and not resected if otherwise. Resection extent of MAP findings were related to MAP above the significance threshold of z>3 ("MEG marked MAP").
Outcome
Seizure outcome was scored according to Engel's classification at last available follow up.
Statistical analysis
Differences of MEG and MAP resection in patients with Engel 1 (completely or almost seizure free)
versus Engel 2-4 (persisting seizures) outcomes were compared using Fisher's exact test. Sensitivity, specificity, positive and negative predictive values were calculated based on concordance of MEG localizations with the resection volume in seizure free patients vs. patients with persisting seizures. A localization was classified as a positive if the localization was within 2 cm of the resection (corresponding to complete or partial resection, see above), negative otherwise. Specificity thus is based on localizations outside this volume in patients with persisting seizures (Engel 2-4). Note that this approach may overestimate specificity (Rikir 2014) . Differences of MEG distances to FCD between patients with BOS and other FCDs were evaluated using a t-test. Statistical analysis was performed using IBM SPSS Statistics 24.0 (Armonk, NY, USA). MEG analysis in our patient cohort demonstrated a close spatial relationship between MEG source and FCD II lesion with a circumscript source localization in the majority of patients, corroborating earlier studies reporting good sensitivity and localization accuracy for MEG in FCD II (Widjaja 2008 , Ishii 2008 , Sueda 2010 , Wilenius 2013 , Mu 2014 , Wang 2012 , Wang 2014 ). In our cohort, MEG sensitivity was as high as 95.2% in FCD II, compared to 70% reported from unselected epilepsy series (Stefan 2003) . Moreover, dipole localizations were within or close to the lesion site in our cohort, matching reports of very active and localized epileptogenicity for FCD II compared to other etiologies (Palmini 1991 , Morioka 1999 , Bast 2004 , Ishii 2008 , Blenkmann 2012 . MEG-MAP analysis in this study was facilitated by preselecting patients with clear-cut FCD II, validated by classic MRI and histopathology in most cases. Interestingly, the MEG source was not constantly found in the center or within the MR lesion, but rather next to edge areas. Of note in this context is that tissue extent in FCD II has been shown to exceed the area of MRI visible lesion, with dysmorphic neurons beyond the borders of the MRI lesion (Tassi 2001) . Areas of signal increase in FLAIR seem to correlate to balloon cell rich parts of the FCD, which in turn are more likely to be electrically silent (Cepeda 2003 , Chassoux 2012 . Therefore, our observation still is compatible with an intralesional MEG-source. The close proximity of MEG sources to the FCD site in our cohort are contrasted by a recent study describing also more remote MEG clusters in some patients, especially concerning small BOS FCDs A C C E P T E D M A N U S C R I P T (Nakajima 2016) . These authors suggest closed-field effects due to the random orientation of neurons within the FCD, low density of neural cells and small sizes of especially BOS FCDs as potential reasons for remote localizations due to lower signal-to-noise ratios (SNR). Furthermore, they used single moving dipole analysis of single spikes (Nakajima 2016) . As a consequence, noise and ongoing, unrelated background activity likely had a stronger impact on the results as our averaged spike approach, which provides and overall better SNR (Bast 2004) . Whereas distances between MEG and the lesion were significantly different between BOS and non-BOS FCDs, BOS FCDs also showed closely related MEG-sources in our study. We also utilized local channel groups centered on the gradient of interest, which further excludes unrelated activity, e.g. in contralateral sensors. The combination of these two strategies may provide access especially to early components of the activity, which may not have propagated as much from the sources in or close to the FCDs. Epileptogenic areas in terms of both interictal irritative zones and ictal onset zones in FCD II are closely related (Bartolomei 2016) , as illustrated by our patient 10, where source localizations of interictal spiking as well as seizure onset were highly concordant (figure 3), again illustrating intrinsic epileptogenicity for FCD II (Cepeda 2003 , Morioka 1999 , Dubeau 1998 , Palmini 1995 .
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Results
Clinical data
Recently, some reports already did imply a potential for combining different diagnostic approaches in FCD II including MRI/MAP, MEG and depth stereo EEG (SEEG): Implantation of a depth electrode into a patient's MAP-lesion, located within a neocortical compartment suggested by semiology, led to good localizing data and successful surgery (Wellmer 2010) . In another FCD II patient receiving invasive recordings with simultaneous MEG as a final step of evaluating a MAP lesion, localizing data were highly concordant (Wang 2012) . Histopathological workup in both cases revealed FCD II and seizure freedom achieved (Wellmer 2010 , Wang 2012 . In another series, resection of "densely clustered" MEG sources in MRI-negative cases related to a postsurgical histopathology of underlying FCD II in some patients and achieved good outcomes (Wilenius 2013) . In further three patients, MEG was highly concordant to the localization of occult FCD II in insular epilepsy (Heers 2012) . Indeed, patient 3 from the latter study is identical to patient 15 in our cohort. Another recent study also reported on linking MAP and MEG data in FCDs (Wang 2014) . In these studies, MAP analysis had been performed in retrospect on preoperative MRIs from patients after surgery for MRI negative epilepsy in order to investigate the value of MAP results versus preOP-MEG data (Wang 2014) : while positive correlations between favourable seizure outcomes and complete resection of the MEG source and/or MAP lesion were reported (Wang 2014) , comparison to our series is difficult due to population heterogeneity in terms of pathology (only two cases of FCD II were included), epilepsy syndrome (high percentage of temporal lobe epilepsy), and less than 50% of patients showing a MAP abnormality overall (Wang 2014 ).
In the same way, a recent report on relationships between structural, magnetic source and stereo-EEG data in FCDs (Bouet 2017) Therefore, invasive recordings are often chosen (Fauser 2012) , and have been discussed to delineate the resective strategy in FCD II best (Chassoux 2008) . Incorporating MEG sources into surgical planning in our view could improve rates of surgical success in FCD II, as suggested by previous reports (Wellmer 2010 , Heers 2012 , and offers potential to optimize but also limit the amount of invasive recording and resection volumes in the future by better targeting (Wellmer 2010 ). An interesting target for future research would be to investigate (and compare to MSI results) electric source imaging (ESI) specifically for FCD II, including high-density EEG (HD-ESI). Some studies using ESI for localizing diagnostics for epilepsy surgery did include FCD patients (Abdallah 2017 , Russo 2016 , Lascano 2016 , Rikir 2014 , Brodbeck 2011 . From these reports, that did include quite heterogenous etiologies, it seems that ESI can be particularily successful in FCD II-related epilepsies.
However, no study so far focussed on tissue-proven FCD II. So far, only one conceptual technical analytic study compared different source localization methods from both HD-EEG and MEG for epileptic activities including clinical application on two patients reported with FCD (Chowdury 2016)
Surgical strategy in FCD II is warranting a more complex approach than pure "lesionectomy" since the tissue lesion in FCD II is usually larger than seen on MRI (Tassi 2001 ), epileptogenicity appears not homogenously distributed within an individual FCD II lesion (Boonyapisit 2003) , and seizure onset zones could relate to parts of large FCD II only (Marusic 2002 and our patient 8, see Figure 2 ). The utility of surgically targeting of MEG clusters in epilepsy surgery has been suggested by earlier studies including FCD II (Vadera 2013 , Mu 2014 , Nakajima 2016 . MEG seems more suitable than SPECT-
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A C C E P T E D M A N U S C R I P T techniques for highlighting FCD II related epileptogenic zones, since MEG is noninvasive, independent of a seizure, and has better properties concerning resolution in time and space (Knowlton 2006) . MEG data could be very helpful in cases with MRI-suspicion of FCD II but missing concordant electroclinical data, as also shown by the various patients from our cohort displaying inconclusive data by standard presurgical methods. We further suggest to integrate MEG into a diagnostic algorithm for patients presenting with "MRI-negative" epilepsy (Wang 2014 , Englot 2015 , Delev 2017 
